a3920p

6-K 1 a3920p.htm DIRECTOR/PDMR SHAREHOLDING a3920p

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

August, 2026

Commission File Number 001-10306

NatWest Group plc

250 Bishopsgate,

London, EC2M 4AA

United Kingdom

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒

Form 40-F ☐

The following information was issued as Company announcements in London, England and is furnished pursuant to General Instruction B to the General Instructions to Form 6-K:

5 August 2026

NatWest Group plc

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE UK MARKET ABUSE REGULATION.

1. NatWest Group plc (the Company) announces that in accordance with the Company Directors' Remuneration Policy or Executive Shareholding Policy, as applicable, the PDMRs set out below each entered into a trading plan on 3 August 2026 in respect of ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) they beneficially own (the Trading Plans).

It was announced in the shareholding requirements section of the Company Directors' Remuneration Policy, on page 137 of the Company 2024 Annual Report and Accounts here, that the Company may offer the opportunity to enter into a trading plan and the Company implemented this in 2025.

The Trading Plans facilitate regular and structured Share dealing to aid normal portfolio management. Under the terms of the Trading Plans, up to 25% of the PDMRs vested Shares (free of regulatory retention requirements) may be sold in accordance with the terms specified in the Trading Plans. The first trading date will be no earlier than 30-days after the Trading Plans were entered into.

The Trading Plans are irrevocable, cannot be amended and will expire on the earliest to occur of (a) 22 July 2027; (b) the date the PDMR ceases to be a PDMR and/or employed by the Company or a member of the Company's group; and (c) the sale of the maximum number of Shares specified in the Trading Plan agreement.

Name of PDMR	Position of PDMR
Paul Thwaite	Group Chief Executive Officer
Katie Murray	Group Chief Financial Officer
Solange Chamberlain	CEO, Retail

The above transactions took place outside a trading venue.

2. The Company announces that the PDMR set out below has sold Shares on the date and at the price indicated:

Name of PDMR	Position of PDMR	No. of Shares sold	Sale price	Date of transaction
Robert Begbie	CEO, Commercial & Institutional	137,547	£7.2456	04/08/2026

The above transaction took place on the London Stock Exchange (XLON).

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share.

Legal Entity Identifier: 2138005O9XJIJN4JPN90

For further information contact:

NatWest Group Investor Relations

Claire Kane

Director of Investor Relations

+44 20 7672 1758

NatWest Group Media Relations

+44(0)131 523 4205

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		NatWest Group plc (Registrant)


Date:	05 August 2026		By:	/s/ Mark Stevens

			Name:	Mark Stevens
			Title:	Assistant Secretary